Brought to you by 
Watson to buy drug delivery company TheraTech in stock swap
13 Jul 1999
Executive Summary
Watson Pharmaceuticals (proprietary and off-patent drugs) will buy drug delivery company TheraTech in a stock swap that values TheraTech at about $300mm. The companies expect the transaction to close in the first quarter of 1999.
Deal Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Pulmonary
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com